Pacific Biosciences of California, Inc. is a biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. They describe their platform as single molecule real time sequencing (SMRT), based on the properties of zero-mode waveguides. Their first commercial product, the PacBio RS, was sold to a limited set of customers in 2010 and was commercially released in early 2011. A new version of the sequencer called the PacBio RS II was released in April 2013. On 25 September 2013 a partnership between Pacific Biosciences and Roche Diagnostics was announced for the development of in vitro diagnostic products using the technology, with Roche providing in the deal. In 2015, the company launched a new sequencing instrument called the Sequel System with approximately 7-fold greater capacity than the PacBio RS II.HistoryThe company was founded based on research done at Cornell University, that combined semiconductor processing and photonics with biotechnology research. It was initially founded under the name Nanofluidics, Inc. The company raised nearly in six rounds of primarily venture capital financing, making it one of the most capitalized startups in 2010 leading up to their public offering in October of that year. Key investors included Mohr Davidow Ventures, Kleiner, Perkins, Caufield & Byers, Alloy Ventures, and Wellcome Trust.
Location: United States, California, Menlo Park
Employees: 1-10
Phone: +1 650-521-8000
Total raised: $279M
Investors 3
Funding Rounds 5
| Date | Series | Amount | Investors |
| 14.07.2010 | Series F | $109M | - |
| 21.06.2010 | Series F | $50M | - |
| 08.10.2009 | - | $2M | - |
| 13.08.2009 | - | $68M | - |
| 15.01.2007 | - | $50M | Kleiner Pe... |
Mentions in press and media 23
| Date | Title | Description |
| 10.02.2021 | SoftBank to invest $900 million in gene sequencing firm Pacific Biosciences | By Reuters Staff 1 Min Read FILE PHOTO: The logo of SoftBank Group Corp is displayed at SoftBank World 2017 conference in Tokyo, Japan, July 20, 2017. REUTERS/Issei Kato/File Photo GLOBAL BUSINESS WEEK AHEAD (Reuters) - SoftBank Group Corp ... |
| 10.02.2021 | Pacific Biosciences spikes 29% after announcing a $900 million investment from SoftBank | Pacific Biosciences stock skyrocketed on Wednesday amid a reported $900 million investment from SoftBank. SoftBank's SB NorthStar unit will buy $900 million of notes with an initial conversion price of $43.50 per share. The SB NorthStar uni... |
| 15.11.2012 | The $1,000 genome question has turned into, “How can we understand this data?” | Life Technologies and Harvard Medical School professor George Church may be the only ones who have officially thrown their hats in the ring for the $10 million Archon Genomics X Prize, but many others have made ambitious promises in the que... |
| 29.03.2012 | The Cloud Will Cure Cancer | Editor’s note: Mark Kaganovich is founder of SolveBio and a doctoral candidate in genetics at Stanford University. Follow him on Twitter @markkaganovich. Much ink has been spilled on the huge leaps in communications, social networking, and ... |
| 02.02.2011 | Pacific Biosciences scores patent win over Life Technologies | Pacific Biosciences of California Inc. (NSDQ:PACB) won a favorable decision from the U.S. Patent Office over a competitor. The Menlo Park, Calif.-based company began a "patent interference" process against Life Technologies Corp. ... |
| 14.07.2010 | Pacific Biosciences Completes $109M Series F Financing Round | Pacific Biosciences, a Menlo Park, California-based company developing a technology platform for real-time detection of biological events at single molecule resolution, has completed a $109m Series F financing round. The round also includes... |
| 21.06.2010 | Pacific Biosciences Receives $50M Strategic Investment in Series F Round | Pacific Biosciences, a Menlo Park, CA-based private sequencing company, has received a $50m strategic investment from Gen-Probe Incorporated (Nasdaq: GPRO). The investment is part of a larger Series F private round raised by the company, wh... |
| 17.06.2010 | Gen-Probe Invests $50M In Pacific Biosciences | San Diego-based scientific instruments maker Gen-Probe has invested $50M in a Northern California firm developing DNA sequencing technology, Pacific Biosciences. According to the two firms, Gen-Probe made the investment as part of a larger ... |
| 17.06.2010 | Gen-Probe Bets $50M on PacBio | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Gen-Probe (NASDAQ: GPRO), the San Diego-based maker of diagnostics, said today it has invested $50 million in Menlo Park, CA-based Pacific Biosciences, an emerging maker of hi... |
| 10.03.2010 | Morning Read: What’s the most promising VC-backed health firm? | What cost controls? Writing in the Wall Street Journal, Harvard economist David Cutler says that the health overhaul incorporates “virtually all” of the notable ideas about how to control health costs that have emerged in recent years. That... |
Show more